Screening for Colorectal Cancer 2020
This activity has been archived and credit is no longer available.
In this Graham-Shwartz Lecture, invited guest speaker Dr. Douglas K. Rex, M.D. discusses the new 2020 American Cancer Society guidelines for screening for colorectal and associated cancers in different patient populations. He also highlights the changes from previous guidelines and what new evidence supports the 2020 recommendations.
Activity Information
This activity has been archived and credit is no longer available.
Needs Statement
Faculty and trainees within the Department of Medicine who are involved in the care of patients need to be regularly updated with the recent advances and guidelines in the fields of internal medicine and quality improvement to increase clinical knowledge, and to implement the advances and guidelines in clinical practice to enhance the quality of patient care and outcomes.
Educational Objectives
At the conclusion of the session, the participants should be able to:
- Recognize the limitations of FIT, FIT-fecal DNA, and colonoscopy.
- Assess the pros and cons of beginning colorectal cancer screening at age 45 years.
- Distinguish the features of adenoma-cancer and serrated-cancer sequences.
Target Audience
Professional Categories
- Physicians
- Medical Students
- Fellows
- Residents
Specialties
- Internal Medicine
Interest Groups
- Hospital Medicine
Accreditation/Credit Designation
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this enduring material activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Activity Director
Term of Approval
March 1, 2020 through March 31, 2022. Original release date: March 1, 2020.
Disclosure Policy
Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.
In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.
In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.
BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:
Presenter
-
Douglas K. Rex, M.D.
Distinguished Professor Emeritus of Medicine
Indiana University School of Medicine
Disclosure:
- Research Support: EndoAid; Erbe USA Inc.; Medivators; Olympus Corporation
- Consultancy: Aries Pharmaceutical; Boston Scientific; Braintree Laboratories; Endokey; GI Supply; Lumendi, Ltd.; Medtronic; Norgine; Olympus Corporation
- Ownership Interests (stock, stock options, excluding diversified mutual funds): Satisfai Health
Activity Director
Planning Committee Members
-
Stephen B. Greenberg, M.D.
Distinguished Service Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
-
Erica Lescinskas, M.D.
Assistant Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Zaven Sargsayan, M.D.
Assistant Professor
Baylor College of Medicine and Ben Taub Hospital
Disclosure:
Nothing to disclose.
-
Stephanie Sherman, M.D.
Assistant Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Chirayu Shah, M.D., M.Ed.
Associate Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
Health Topics
Presenter: